Pictet Asset Management (UK)’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$20.9M Buy
376,037
+4,256
+1% +$227K 0.02% 510
2021
Q1
$17.4M Buy
371,781
+7,981
+2% +$387K 0.02% 533
2020
Q4
$15.8M Buy
+363,800
New +$13.4M 0.02% 528

Other funds holding HCAT

Pictet Asset Management (UK)'s HCAT Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Health Catalyst (HCAT) stake by 1.1% in Q2 2021, buying an estimated $227K and bringing the position to 376,037 shares worth $20.9M. The position accounts for 0.02% of the portfolio, ranked #510.

Pictet Asset Management (UK) first reported a position in HCAT in Q4 2020 and has held it in 3 quarters since. 198 funds tracked by Wall St. Rank hold HCAT as of Q2 2021.

  • Pictet Asset Management (UK) held 376,037 shares of Health Catalyst worth $20.9M as of Q2 2021.
  • Pictet Asset Management (UK) bought 4,256 Health Catalyst shares in Q2 2021, an estimated $227K.
  • Health Catalyst made up 0.02% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #510 holding.
  • Pictet Asset Management (UK) first reported a position in Health Catalyst in Q4 2020 and has held it in 3 quarters since.
  • 198 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.